IP Library › Granted Patent US 12,336,905
Granted Patent B2
US 12,336,905 · App. 16/969,750 · Granted Jun 24, 2025

Stent and replacement heart valve prosthesis with improved fixation features

Inventors: Georg Rahmig (Pforzheim, DE); Helmut Straubinger (Aschheim, DE); Coralie Marchand (Munich, DE)
Assignee: TRICARES SAS
A61F2/2418A61F2/2427A61F2/848A61F2/91A61F2/9522A61F2210/0014A61F2210/0076A61F2220/0033A61F2220/0041A61F2220/0058A61F2220/0075A61F2230/001A61F2250/0039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,336,905
App. No.
16/969,750
Granted
Jun 24, 2025
Kind
B2
Abstract

Disclosed is an improved stent and a related replacement heart valve prosthesis exhibiting various features for improved fixation and crush resistance. The stent is characterized by an inner stent fixed to an outer stent with connecting struts. The stent and heart valve prosthesis can be used for replacement of a defective endogenous heart valve.

Claims (43)

1. A prosthesis comprising an outer stent that is a laser cut stent and an inner stent that is a laser cut stent, wherein:

(i) the outer stent comprises a proximal outer stent region and a distal outer stent region, wherein the distal outer stent region comprises a connecting strut guide;

(ii) the proximal outer stent region comprises a connecting strut and the inner stent comprises a connecting strut, wherein the connecting strut of the proximal outer stent region and/or the connecting strut of the inner stent is an S-strut;

(iii) the outer stent and the inner stent form a double layer that provides for crush resistance; and

(iv) the connecting strut of the inner stent and the connecting strut of the proximal outer stent region are connected by a connecting means, and

wherein, when implanted, the connecting strut guide is configured to slidably connect to the connecting strut of the inner stent, thereby connecting the inner stent, the proximal outer stent region, and the distal outer stent region in a proximal area of the prosthesis.

2. The prosthesis according to claim 1 , wherein the prosthesis comprises a proximal end, a middle area, and a distal end, and wherein:

a) the proximal end of the prosthesis has a longitudinal dimension of 1 to 25 mm, the middle area of the prosthesis has a longitudinal dimension of 1 to 25 mm, and the distal end of the prosthesis has a longitudinal dimension of 1 to 25 mm;

b) the proximal end, middle area, and distal end of the prosthesis have different outer diameters in an expanded state of the prosthesis;

c) the middle area of the prosthesis has a smaller outer diameter than an outer diameter of the proximal and distal ends of the prosthesis;

d) a radial force in a sub-annular area of the prosthesis is equal to or higher than a radial force in a ventricular or outflow area of the prosthesis; or

e) a radial force of an annular area and/or the distal area of the prosthesis is in a range of 0.5 to 20 N.

3. The prosthesis according to claim 2 , wherein:

a) the longitudinal dimension of the proximal area is from 1 to 5 mm, the longitudinal dimension of the middle area is from 4 to 10 mm, and the longitudinal dimension of the distal area is from 4 to 10 mm;

b) the outer diameter of the proximal, middle, and distal areas are in a range of 40 to 90 mm or 20 to 90 mm in the expanded state of the prosthesis; and/or

c) the middle area forms a groove.

4. The prosthesis of claim 1 , further comprising a valve fixed thereto, thereby forming a heart valve prosthesis.

5. The prosthesis according to claim 4 , wherein the valve is fixed to the prosthesis by one or more sutures.

6. The prosthesis according to claim 4 , wherein the inner stent:

a) has an inner diameter of between 8 mm and 40 mm;

b) has an outer diameter of between 15 mm and 41 mm; and/or

c) comprises an expanded configuration, wherein the inner stent has a longitudinal dimension of 8 to 35 mm in the expanded configuration.

7. The prosthesis according to claim 4 , wherein:

a) the outer stent forms an angle with the inner stent;

b) the outer stent is a nitinol stent;

c) the prosthesis can be crimped to a diameter of 16 to 40 French, 16 to 35 French, 20 to 35 French, or 25 to 35 French; and/or

d) the prosthesis is configured for deployment by way of catheter delivery.

8. The prosthesis according to claim 7 , wherein:

a) the angle formed by the outer stent with the inner stent is 5 to 90°, 25 to 50°, or 35 to 45°; and/or

b) the catheter delivery is transfemoral catheter delivery.

9. The prosthesis according to claim 7 , wherein:

a) the outer stent is characterized by 10 to 30 cells circumferentially in the proximal and/or distal area and/or the inner stent is characterized by 4 to 30, 4 to 24, or 10 to 30 cells circumferentially in three, four, or five rows.

10. The prosthesis according to claim 1 , wherein the connecting means is or comprises one or more sutures, a welding, one or more screws, or one or more clips.

11. The prosthesis according to claim 10 , wherein the one or more clips are characterized by an interlocking tooth and an interlocking yoke and a cover.

12. The prosthesis according to claim 1 , wherein the inner stent and the proximal outer stent region are connected with 4 to 24 combinations of connecting struts and connecting means and wherein the distal outer stent region comprises one connecting strut guide for each of the connecting struts of the inner stent.

13. The prosthesis according to claim 12 , wherein each of the inner stent and the proximal outer stent region comprises 6 to 14, 8 to 18, 8 to 12, or 12 of the connecting struts that are joined by the connecting means.

14. A method of replacement heart valve therapy comprising implanting the heart valve prosthesis according to claim 4 in a subject in need thereof.

15. The method of claim 14 , wherein the heart valve prosthesis is delivered using a catheter, wherein the method further comprises loading the heart valve prosthesis onto the catheter, introducing the catheter into the subject, moving the catheter to a target site, and deploying the heart valve prosthesis at the target site.

16. The method of claim 15 , wherein the heart valve prosthesis is delivered by transfemoral delivery.

17. The prosthesis of claim 1 , wherein the connecting means releasably joins the inner stent and the outer stent.

18. The prosthesis of claim 17 , wherein the connecting means comprises one or more sutures, a welding, one or more screws, or one or more clips.

19. The prosthesis of claim 1 , wherein the outer stent further comprises a middle area and a distal area, wherein the middle area and/or the distal area comprise a circumferential stabilizer positioned inside and/or outside the outer stent.

20. The prosthesis of claim 19 , wherein the circumferential stabilizer (i) is in a bent, zig-zag, or undulating geometry and/or (ii) is interwoven in the middle area of the outer stent and/or the distal area of the outer stent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2020
From: RAHMIG, GEORG; STRAUBINGER, HELMUT; MARCHAND, CORALIE
To: TRICARES SAS
Reel/Frame 054011/0404 →
Priority Claims (1)
EP 18000144 · Feb 15, 2018 · regional
Continuity (1)
Related Publication 20210000593A1 · Jan 7, 2021
References Cited (70)
US 6669724B2 · Park · 2003 [cited by examiner]
US 8070800B2 · Lock et al. · 2011 [cited by applicant]
US 8628571B1 · Hacohen · 2014 [cited by examiner]
US 9066801B2 · Kovalsky · 2015 [cited by examiner]
US 10039639B2 · Marchand · 2018 [cited by examiner]
US 10245143B2 · Gross · 2019 [cited by examiner]
US 10543077B2 · Tuval · 2020 [cited by examiner]
US 10702378B2 · Miyashiro · 2020 [cited by examiner]
US 10945839B2 · Alon · 2021 [cited by examiner]
US 10952851B2 · Marchand · 2021 [cited by examiner]
US 11109965B2 · Iyer · 2021 [cited by examiner]
US 20030144725A1 · Lombardi · 2003 [cited by examiner]
US 20040093060A1 · Seguin · 2004 [cited by examiner]
US 20080275540A1 · Wen · 2008 [cited by applicant]
US 20090088836A1 · Bishop · 2009 [cited by examiner]
US 20090138079A1 · Tuval et al. · 2009 [cited by applicant]
US 20090240320A1 · Tuval · 2009 [cited by examiner]
US 20110137397A1 · Chau · 2011 [cited by examiner]
US 20110245911A1 · Quill · 2011 [cited by examiner]
US 20110264207A1 · Bonhoeffer et al. · 2011 [cited by applicant]
US 20120022639A1 · Hacohen · 2012 [cited by examiner]
US 20120083874A1 · Dale et al. · 2012 [cited by applicant]
US 20120323316A1 · Chau · 2012 [cited by examiner]
US 20130035759A1 · Gross · 2013 [cited by examiner]
US 20130204357A1 · Thill et al. · 2013 [cited by applicant]
US 20130304200A1 · McLean · 2013 [cited by examiner]
US 20130317603A1 · McLean · 2013 [cited by examiner]
US 20140144000A1 · Creaven et al. · 2014 [cited by applicant]
US 20140180401A1 · Quill · 2014 [cited by examiner]
US 20140207231A1 · Hacohen · 2014 [cited by examiner]
US 20140277409A1 · Bortlein · 2014 [cited by examiner]
US 20140331475A1 · Duffy et al. · 2014 [cited by applicant]
US 20140358224A1 · Tegels · 2014 [cited by examiner]
US 20150005863A1 · Para · 2015 [cited by applicant]
US 20150039081A1 · Costello · 2015 [cited by examiner]
US 20150081000A1 · Hossainy et al. · 2015 [cited by applicant]
US 20150216661A1 · Hacohen · 2015 [cited by examiner]
US 20150351906A1 · Hammer · 2015 [cited by examiner]
US 20160030169A1 · Shahriari · 2016 [cited by applicant]
US 20160038280A1 · Morriss · 2016 [cited by examiner]
US 20160151153A1 · Sandstrom · 2016 [cited by examiner]
US 20160270910A1 · Birmingham · 2016 [cited by examiner]
US 20160331529A1 · Marchand · 2016 [cited by examiner]
US 20170172738A1 · Kassas · 2017 [cited by examiner]
US 20170181852A1 · Kassas · 2017 [cited by examiner]
US 20170216027A1 · Marchand et al. · 2017 [cited by applicant]
US 20170231761A1 · Cohen-Tzemach et al. · 2017 [cited by applicant]
US 20180055629A1 · Oba et al. · 2018 [cited by applicant]
US 20180147053A1 · Tuval · 2018 [cited by examiner]
US 20180185142A1 · Quill · 2018 [cited by examiner]
US 20180338832A1 · Ganesan et al. · 2018 [cited by applicant]
US 20190167421A1 · Chau · 2019 [cited by examiner]
US 20190262129A1 · Cooper · 2019 [cited by examiner]
US 20190321171A1 · Morriss · 2019 [cited by examiner]
US 20190365538A1 · Chambers · 2019 [cited by examiner]
US 20200315794A1 · Quill · 2020 [cited by examiner]
US 20210000593A1 · Rahmig et al. · 2021 [cited by applicant]
US 20210196459A1 · Marchand et al. · 2021 [cited by applicant]
US 20210315691A1 · Rahmig et al. · 2021 [cited by applicant]
EP 3202371A1 · 2017 [cited by applicant]
WO WO2010008548A2 · 2010 [cited by applicant]
WO WO2012178115A2 · 2012 [cited by applicant]
WO WO2015107226A1 · 2015 [cited by applicant]
WO WO2018197041A1 · 2018 [cited by applicant]
WO WO2019158628A1 · 2019 [cited by applicant]
International Search Report and Written opinion for International Application No. PCT/EP2019/053633, mailed Mar. 5, 2019 (12 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2015/051037, mailed May 6, 2015 (9 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2019/073768, mailed Dec. 13, 2019 (10 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2019/075216, mailed Feb. 7, 2020 (10 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2020/051955, mailed Mar. 26, 2020 (12 pages). [cited by applicant]